Results for this period
Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
In Electronics, orders for functional materials and precision-machined components remained firm, supported by demand for semiconductors related to generative AI. In Mobility, the economic recovery in Southeast Asia, orders for brake-related components from the Vietnam plant and cost-reduction initiatives at the Thailand plant contributed to results. In Medical and Precision Equipment, orders for medical equipment components and printer-related components from the Vietnam and Philippines plants, together with cost-reduction initiatives at plants across ASEAN, contributed to results.
Not applicable (no matters to report in the notes on the going concern assumption)
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥46,403 million (YoY +3.4%) |
| Operating profit | ¥2,079 million (YoY +5.5%) |
| Ordinary income | ¥2,269 million (YoY +7.8%) |
| Profit attributable to owners of the parent | ¥1,441 million (YoY +3.2%) |
| Net income per share | ¥159.32 |
| Operating Margin | 4.5% |
| Equity ratio | End of the current fiscal period 49.3% / End of previous period 50.9% |
| Total assets | ¥36,518 million |
| Net assets | ¥17,992 million |
| Cash flows from operating activities | ¥308 million |
| Cash flows from investing activities | ¥-1,091 million |
| Cash flows from financing activities | ¥1,127 million |
| Cash and cash equivalents at end of period | ¥6,718 million |
| Full-year earnings forecast | Net Sales ¥47,300 million (YoY +1.9%) / Operating profit ¥2,050 million (YoY -1.4%) / Ordinary income ¥2,000 million (YoY -11.9%) / Net income ¥1,410 million (YoY -2.2%) |
| Annual Dividend Forecast | ¥154 per share → ¥79 per share（-48.7%） |
| Payout ratio | 50.8% |
| Segment revenue | Electronics ¥21,556 million (YoY +3.4%), Mobility ¥17,676 million (YoY +4.9%), Medical and Precision Equipment ¥7,305 million (YoY -1.5%), Other ¥203 million (YoY -5.6%) |
| Segment profit | Electronics ¥1,775 million (YoY +15.8%), Mobility ¥1,162 million (YoY +0.2%), Medical and Precision Equipment ¥706 million (YoY +78.2%), Other ¥59 million (YoY -5.0%) |
| Depreciation and amortization | ¥1,611 million |
| Impairment loss | ¥20 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥21 million, Gain on sale of investment securities ¥0 million / Extraordinary loss Losses on disposal of fixed assets ¥11 million, Impairment Loss on Investment Securities ¥247 million, Impairment Losses ¥20 million |
| Disclosure regarding the going concern assumption | Not applicable (no matters to report in the notes on the going concern assumption) |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 / Excluded 0 / Company name Not disclosed |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 9,127,338 Shares |
| Treasury Shares at Period-End | 60,554 Shares |
| Factors Behind Changes in Business Performance | In Electronics, orders for functional materials and precision-machined components remained firm, supported by demand for semiconductors related to generative AI. In Mobility, the economic recovery in Southeast Asia, orders for brake-related components from the Vietnam plant and cost-reduction initiatives at the Thailand plant contributed to results. In Medical and Precision Equipment, orders for medical equipment components and printer-related components from the Vietnam and Philippines plants, together with cost-reduction initiatives at plants across ASEAN, contributed to results. |
Items this document does not state (4)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Results were supported by demand for semiconductors related to generative AI, an economic recovery in Southeast Asia, orders related to automobiles and medical equipment, and cost-reduction initiatives at each plant. For the fiscal year ending March 2027, however, profit is expected to remain at the previous year's level or decline because the impact of the situation in Iran on raw-material supplies and the extent of increases in procured-material prices cannot be forecast with certainty.